Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma.

Papageorgiou SG, Thomopoulos TP, Spathis A, Bouchla A, Glezou I, Stavroulaki G, Gkontopoulos K, Bazani E, Foukas PG, Pappa V.

Hematol Oncol. 2019 Oct 28. doi: 10.1002/hon.2685. [Epub ahead of print] No abstract available.

PMID:
31657017
2.

Pericardial Synovial Sarcoma: Case Report, Literature Review and Pooled Analysis.

Duran-Moreno J, Kampoli K, Kapetanakis EI, Mademli M, Koufopoulos N, Foukas PG, Kostopanagiotou K, Tomos P, Koumarianou A.

In Vivo. 2019 Sep-Oct;33(5):1531-1538. doi: 10.21873/invivo.11633.

3.

Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report.

Bonou M, Kapelios CJ, Marinakos A, Adamopoulos S, Diamantopoulos P, Foukas PG, Kaklamanis L, Korkolopoulou P, Barbetseas J, Viniou NA.

BMC Cancer. 2019 Mar 1;19(1):191. doi: 10.1186/s12885-019-5405-y.

4.

Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma.

Bordry N, Broggi MAS, de Jonge K, Schaeuble K, Gannon PO, Foukas PG, Danenberg E, Romano E, Baumgaertner P, Fankhauser M, Wald N, Cagnon L, Abed-Maillard S, Maby-El Hajjami H, Murray T, Ioannidou K, Letovanec I, Yan P, Michielin O, Matter M, Swartz MA, Speiser DE.

Oncoimmunology. 2018 May 31;7(8):e1462878. doi: 10.1080/2162402X.2018.1462878. eCollection 2018.

5.

Safety profile after prolonged C3 inhibition.

Reis ES, Berger N, Wang X, Koutsogiannaki S, Doot RK, Gumas JT, Foukas PG, Resuello RRG, Tuplano JV, Kukis D, Tarantal AF, Young AJ, Kajikawa T, Soulika AM, Mastellos DC, Yancopoulou D, Biglarnia AR, Huber-Lang M, Hajishengallis G, Nilsson B, Lambris JD.

Clin Immunol. 2018 Dec;197:96-106. doi: 10.1016/j.clim.2018.09.004. Epub 2018 Oct 10.

PMID:
30217791
6.

T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

Neubert NJ, Schmittnaegel M, Bordry N, Nassiri S, Wald N, Martignier C, Tillé L, Homicsko K, Damsky W, Maby-El Hajjami H, Klaman I, Danenberg E, Ioannidou K, Kandalaft L, Coukos G, Hoves S, Ries CH, Fuertes Marraco SA, Foukas PG, De Palma M, Speiser DE.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaan3311. doi: 10.1126/scitranslmed.aan3311.

7.

Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights.

Foukas PG, Tsiodras S, Economopoulou P, Spathis A, Mademli M, Leventakos K, Psyrri A, Karakitsos P, Panayiotides IG.

IDCases. 2018 Feb 8;11:101-103. doi: 10.1016/j.idcr.2018.01.013. eCollection 2018.

8.

Neoantigen-based cancer immunotherapy.

Bobisse S, Foukas PG, Coukos G, Harari A.

Ann Transl Med. 2016 Jul;4(14):262. doi: 10.21037/atm.2016.06.17. Review.

9.

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.

Papageorgiou SG, Kontos CK, Foukas PG, Panopoulou E, Vasilatou D, Rapti SM, Gkontopoulos K, Bazani E, Panayiotides IG, Dimitriadis G, Scorilas A, Pappa V.

Leuk Lymphoma. 2016 Sep;57(9):2199-203. doi: 10.3109/10428194.2015.1126588. Epub 2016 Jan 14. No abstract available.

PMID:
27442703
10.

Multiplexed tissue biomarker imaging.

Stack EC, Foukas PG, Lee PP.

J Immunother Cancer. 2016 Feb 16;4:9. doi: 10.1186/s40425-016-0115-3. eCollection 2016. No abstract available.

11.

Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

Yuan J, Hegde PS, Clynes R, Foukas PG, Harari A, Kleen TO, Kvistborg P, Maccalli C, Maecker HT, Page DB, Robins H, Song W, Stack EC, Wang E, Whiteside TL, Zhao Y, Zwierzina H, Butterfield LH, Fox BA.

J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016. Review.

12.

Identification of melanoma cells and lymphocyte subpopulations in lymph node metastases by FTIR imaging histopathology.

Wald N, Bordry N, Foukas PG, Speiser DE, Goormaghtigh E.

Biochim Biophys Acta. 2016 Feb;1862(2):202-12. doi: 10.1016/j.bbadis.2015.11.008. Epub 2015 Nov 21.

13.

IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.

Bahri R, Pateras IS, D'Orlando O, Goyeneche-Patino DA, Campbell M, Polansky JK, Sandig H, Papaioannou M, Evangelou K, Foukas PG, Gorgoulis VG, Bulfone-Paus S.

Oncoimmunology. 2015 Jan 22;4(9):e1002721. eCollection 2015 Sep.

14.

Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb.

Georgoutsou-Spyridonos M, Ricklin D, Pratsinis H, Perivolioti E, Pirmettis I, Garcia BL, Geisbrecht BV, Foukas PG, Lambris JD, Mastellos DC, Sfyroera G.

J Immunol. 2015 Oct 15;195(8):3946-58. doi: 10.4049/jimmunol.1500966. Epub 2015 Sep 4.

15.

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.

Romano E, Kusio-Kobialka M, Foukas PG, Baumgaertner P, Meyer C, Ballabeni P, Michielin O, Weide B, Romero P, Speiser DE.

Proc Natl Acad Sci U S A. 2015 May 12;112(19):6140-5. doi: 10.1073/pnas.1417320112. Epub 2015 Apr 27.

16.

Recent advances in intestinal lymphomas.

Foukas PG, de Leval L.

Histopathology. 2015 Jan;66(1):112-36. doi: 10.1111/his.12596. Review.

PMID:
25639480
17.

Complement deficiency promotes cutaneous wound healing in mice.

Rafail S, Kourtzelis I, Foukas PG, Markiewski MM, DeAngelis RA, Guariento M, Ricklin D, Grice EA, Lambris JD.

J Immunol. 2015 Feb 1;194(3):1285-91. doi: 10.4049/jimmunol.1402354. Epub 2014 Dec 29.

18.

Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.

Lytras D, Leontara V, Kefala M, Foukas PG, Giannakou N, Pouliakis A, Dervenis C, Panayiotides IG, Karakitsos P.

Pancreas. 2015 Jan;44(1):87-92. doi: 10.1097/MPA.0000000000000197.

PMID:
25058886
19.

Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes.

Kefala M, Papageorgiou SG, Kontos CK, Economopoulou P, Tsanas A, Pappa V, Panayiotides IG, Gorgoulis VG, Patsouris E, Foukas PG.

Leuk Res. 2013 Nov;37(11):1576-82. doi: 10.1016/j.leukres.2013.08.018. Epub 2013 Sep 5.

PMID:
24054861
20.

Clinical reasoning: a 51-year-old man with cervical pain and progressively deteriorating gait.

Rallis D, Tsirigotis P, Arvaniti C, Sgouros S, Foukas PG, Oikonomopoulos N, Andronas N, Panayiotides IG, Kouloulias V, Papageorgiou S, Voumvourakis K, Stamboulis E.

Neurology. 2013 May 28;80(22):e230-4. doi: 10.1212/WNL.0b013e318294b2bf.

21.

A rare case of dysphagia in a severely immunocompromised patient.

Sioulas AD, Panayiotides IG, Kavatha D, Foukas PG, Antonakos N, Triantafyllou K.

Arch Med Sci. 2013 Apr 20;9(2):381-3. doi: 10.5114/aoms.2012.31254. Epub 2012 Oct 16. No abstract available.

22.

Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation.

Kourtzelis I, Rafail S, DeAngelis RA, Foukas PG, Ricklin D, Lambris JD.

FASEB J. 2013 Jul;27(7):2768-76. doi: 10.1096/fj.12-225888. Epub 2013 Apr 4.

23.

Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma.

Hountis P, Foukas PG, Matthaios D, Kefala M, Chelis L, Pantelidaki A, Panayiotides IG, Karakitsos P, Kakolyris S.

Onco Targets Ther. 2012;5:363-73. doi: 10.2147/OTT.S36474. Epub 2012 Nov 21.

24.

γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer.

Matthaios D, Foukas PG, Kefala M, Hountis P, Trypsianis G, Panayiotides IG, Chatzaki E, Pantelidaki E, Bouros D, Karakitsos P, Kakolyris S.

Onco Targets Ther. 2012;5:309-14. doi: 10.2147/OTT.S36995. Epub 2012 Oct 30.

25.

Oral lichen planus as a preneoplastic inflammatory model.

Georgakopoulou EA, Achtari MD, Achtaris M, Foukas PG, Kotsinas A.

J Biomed Biotechnol. 2012;2012:759626. doi: 10.1155/2012/759626. Epub 2012 May 17. Review.

26.

A case of gastric ischemic necrosis.

Papanikolaou IS, Foukas PG, Sioulas A, Beintaris I, Panagopoulos P, Karamanolis G, Panayiotides IG, Dimitriadis G, Triantafyllou K.

Endoscopy. 2011;43 Suppl 2 UCTN:E342. doi: 10.1055/s-0030-1256795. Epub 2011 Oct 21. No abstract available.

PMID:
22020717
27.

CD20 expression in angioimmunoblastic T cell lymphoma.

Foukas PG, Kefala M, Papageorgiou S, Tsirigotis P, Panayiotidis P, Korkolopoulou P, Spathis A, Dervenoulas J, Patsouris E, Karakitsos P, Panayiotides IG.

Leuk Lymphoma. 2012 Feb;53(2):345-7. doi: 10.3109/10428194.2011.602768. Epub 2011 Nov 15. No abstract available.

PMID:
21919822
28.

Synchronous well differentiated neuroendocrine tumour and gastrointestinal stromal tumour of the stomach: a case report.

Samaras VD, Foukas PG, Triantafyllou K, Leontara V, Tsapralis D, Tsompanidi EM, Machairas A, Panayiotides IG.

BMC Gastroenterol. 2011 Mar 24;11:27. doi: 10.1186/1471-230X-11-27. Review.

29.

Simultaneous occurrence of Warthin-like papillary carcinoma and lymphoma of the mucosa associated lymphoid tissue in Hashimoto thyroiditis.

Panayiotides IG, Foukas PG, Meristoudis C, Zourla AP, Peros G, Karakitsos P.

J Clin Pathol. 2010 Jul;63(7):662-3. doi: 10.1136/jcp.2010.076299. No abstract available.

PMID:
20591920
30.

Wound healing after laser skin resurfacing: the effect of a silver sulfadiazine-hyaluronic acid-containing cream under an occlusive dressing.

Kontoes PP, Vrettou CP, Loupatatzi AN, Marayiannis KV, Foukas PG, Vlachos SP.

J Cosmet Laser Ther. 2010 Feb;12(1):10-3. doi: 10.3109/14764170903449752.

PMID:
20020835
31.

Malignant rhabdoid tumor of the large intestine.

Mastoraki A, Kotsilianou O, Papanikolaou IS, Foukas PG, Sakorafas G, Safioleas M.

Int J Colorectal Dis. 2009 Nov;24(11):1357-8. doi: 10.1007/s00384-009-0717-z. Epub 2009 May 9. No abstract available.

PMID:
19430801
32.

The regulation of liver cell survival by complement.

Markiewski MM, DeAngelis RA, Strey CW, Foukas PG, Gerard C, Gerard N, Wetsel RA, Lambris JD.

J Immunol. 2009 May 1;182(9):5412-8. doi: 10.4049/jimmunol.0804179.

33.

Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer.

Dimitriadis E, Trangas T, Milatos S, Foukas PG, Gioulbasanis I, Courtis N, Nielsen FC, Pandis N, Dafni U, Bardi G, Ioannidis P.

Int J Cancer. 2007 Aug 1;121(3):486-94.

34.

Alterations in the proliferating compartment of gastric mucosa during Helicobacter pylori infection: the putative role of epithelial cells expressing p27(kip1).

Sougioultzis S, Foukas PG, Tzivras M, Kourtessas D, Gorgoulis VG, Davaris P, Archimandritis AJ.

Mod Pathol. 2003 Nov;16(11):1076-85.

35.

Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?

Foukas PG, Tsilivakos V, Zacharatos P, Mariatos G, Moschos S, Syrianou A, Asimacopoulos PJ, Bramis J, Fotiadis C, Kittas C, Gorgoulis VG.

Anticancer Res. 2001 Jul-Aug;21(4A):2609-15.

PMID:
11724329
36.

Molecular aspects of multiple myeloma.

Kastrinakis NG, Gorgoulis VG, Foukas PG, Dimopoulos MA, Kittas C.

Ann Oncol. 2000 Oct;11(10):1217-28. Review.

PMID:
11106109

Supplemental Content

Loading ...
Support Center